(4-(2-(Pyridin-3-yloxy)ethyl)piperazin-1-yl)(1H-pyrrol-2-yl)methanone

ID: ALA4525545

PubChem CID: 71724974

Max Phase: Preclinical

Molecular Formula: C16H20N4O2

Molecular Weight: 300.36

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(c1ccc[nH]1)N1CCN(CCOc2cccnc2)CC1

Standard InChI:  InChI=1S/C16H20N4O2/c21-16(15-4-2-6-18-15)20-9-7-19(8-10-20)11-12-22-14-3-1-5-17-13-14/h1-6,13,18H,7-12H2

Standard InChI Key:  IOPOIQNKSCJDRU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   23.3127   -3.8380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3102   -3.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0208   -2.6019    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5972   -2.6061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7358   -3.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4443   -2.6050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4461   -1.7833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7332   -1.3746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0185   -1.7835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1583   -1.3753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8698   -1.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5819   -1.3764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2893   -1.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2846   -2.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9953   -3.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7084   -2.6063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7065   -1.7808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9952   -1.3754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6540   -4.3248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9828   -4.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7318   -5.0947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9117   -5.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  3  5  1  0
  3  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  1 19  1  0
 19 22  1  0
 20  1  2  0
 20 21  1  0
 21 22  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4525545

   [4-(2-pyridin-3-yloxyethyl)piperazin-1-yl]-(1H-pyrrol-2-yl)methanone

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 300.36

Molecular Weight (Monoisotopic): 300.1586

AlogP: 1.25

#Rotatable Bonds: 5

Polar Surface Area: 61.46

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.37

CX LogP: 0.54

CX LogD: 0.51

Aromatic Rings: 2

Heavy Atoms: 22

QED Weighted: 0.90

Np Likeness Score: -1.79

References

1. Moritz AE, Free RB, Weiner WS, Akano EO, Gandhi D, Abramyan A, Keck TM, Ferrer M, Hu X, Southall N, Steiner J, Aubé J, Shi L, Frankowski KJ, Sibley DR..  (2020)  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.,  63  (10): [PMID:32342685] [10.1021/acs.jmedchem.0c00424]

Source

Source(1):

• Scientific Literature